This study aimed to explore whether PCF/TAT was associated with NAFLD/abdominal obesity (AO) phenotypes in different high-sensitivity C-reactive protein (hs-CRP) levels. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.